ESR1 and breast carcinoma: Moreover stimulation of AMPK by metformin led to decrease cell proliferation in both estrogen receptor alpha (ER alpha) negative and positive human breast cancer cell lines, in addition to the inhibition of aromatase expression in human breast adipose stromal cells [58, 59].